JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-0.38 Cr | ₹-0.01 Cr | ₹0.29 Cr | ₹0.49 Cr | ₹0.08 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of JENBURKT PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-0.38 Cr |
Mar2024 | ₹-0.01 Cr |
Mar2023 | ₹0.29 Cr |
Mar2022 | ₹0.49 Cr |
Mar2021 | ₹0.08 Cr |
How is Deferred Tax Assets / Liabilities of JENBURKT PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-0.38 Cr | Negative | |
Mar2024 | ₹-0.01 Cr | Negative | |
Mar2023 | ₹0.29 Cr | -39.59 | |
Mar2022 | ₹0.49 Cr | 484.34 | |
Mar2021 | ₹0.08 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹442.0 Cr | -5.1% | -10% | -3.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,140.0 Cr | 0.6% | 3.6% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,290.0 Cr | 1% | 9.4% | 8% | Stock Analytics | |
CIPLA | ₹132,417.0 Cr | 0.9% | 1.2% | -0.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,839.0 Cr | 1.7% | 1% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,031.0 Cr | -0.5% | -4.2% | -6.3% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -5.1% |
-10% |
-3.5% |
SENSEX | 2.5% |
2% |
3.1% |
You may also like the below Video Courses